Filing Details
- Accession Number:
- 0001209191-23-013826
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-28 18:00:47
- Reporting Period:
- 2023-02-24
- Accepted Time:
- 2023-02-28 18:00:47
- SEC Url:
- Form 4 Filing
Issuer
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1357529 | M Christopher Hix | 2711 Centerville Road Suite 400 Wilmington DE 19808 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Acquisiton | 2023-02-24 | 1,815 | $0.00 | 38,459 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 | Acquisiton | 2023-02-24 | 7,625 | $0.00 | 46,084 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2023-02-27 | 908 | $57.65 | 45,176 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 | Disposition | 2023-02-27 | 3,813 | $57.65 | 41,363 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Restricted Stock Units | Disposition | 2023-02-24 | 1,815 | $0.00 | 1,815 | $0.00 |
| Common Stock, Par Value $0.001 | Restricted Stock Units | Disposition | 2023-02-24 | 7,625 | $0.00 | 7,625 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-02-24 | 2023-02-24 | No | 4 | M | Direct |
| 0 | 2023-02-24 | 2023-02-24 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units.
- These restricted stock units vested in full on February 24, 2023.
- In connection with ESAB's separation from Colfax Corporation ("Colfax") on April 4, 2022, the reporting person's Colfax performance-based restricted stock units were converted into ESAB time-based restricted stock units. These ESAB restricted stock units represent converted Colfax performance-based restricted stock units that vested in full on February 24, 2023.
Billionaire Hedge Funds
